MHRA applauds EU clinical trials advances as it sees the efforts pay off
This article was originally published in Clinica
Executive Summary
EU clinical trials requirements have been under the spotlight for several years, not least because of concerns related to the safety of implants. But efforts to improve the clinical trials system are now paying off, says the UK medical device regulatory agency's Dr Susanne Ludgate. In an interview with Clinica's Amanda Maxwell, she said there was cause for optimism, although some residual concerns remain